Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -42.47%112.6M | 25.70%424.03M | 58.42%195.73M | -2.21%337.33M | -32.18%123.55M | -10.55%344.95M | -4.72%182.17M | -14.87%385.61M | -19.14%191.21M | -20.58%452.96M |
| Operating income | -42.47%112.6M | 25.70%424.03M | 58.42%195.73M | -2.21%337.33M | -32.18%123.55M | -10.55%344.95M | -4.72%182.17M | -14.87%385.61M | -19.14%191.21M | -20.58%452.96M |
| Cost of sales | 46.24%-82.55M | -23.56%-335M | -71.61%-153.55M | -41.97%-271.13M | 6.30%-89.48M | 36.63%-190.97M | 47.40%-95.49M | 25.85%-301.34M | 13.57%-181.56M | 22.99%-406.4M |
| Operating expenses | 46.24%-82.55M | -23.56%-335M | -71.61%-153.55M | -41.97%-271.13M | 6.30%-89.48M | 36.63%-190.97M | 47.40%-95.49M | 25.85%-301.34M | 13.57%-181.56M | 22.99%-406.4M |
| Gross profit | -28.74%30.06M | 34.48%89.03M | 23.80%42.18M | -57.00%66.21M | -60.69%34.07M | 82.71%153.98M | 798.89%86.68M | 80.98%84.28M | -63.47%9.64M | 9.33%46.57M |
| Administrative expenses | 33.47%-33.37M | -8.26%-108.29M | -18.21%-50.15M | -23.87%-100.03M | -0.59%-42.43M | 37.55%-80.76M | 8.90%-42.18M | -24.25%-129.32M | 5.45%-46.3M | -13.87%-104.08M |
| Impairment and provision | -99.70%14K | 100.46%36K | -27.59%4.62M | 15.30%-7.84M | 548.21%6.38M | 66.22%-9.26M | -410.04%-1.42M | 41.78%-27.4M | 87.94%-279K | -775.76%-47.07M |
| -Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | -3,192.00%-1.65M | ---- | 72.22%-50K | ---- | ---180K |
| -Other impairment is provision | -99.70%14K | 100.46%36K | -27.59%4.62M | -3.02%-7.84M | 548.21%6.38M | 72.17%-7.61M | -410.04%-1.42M | 41.67%-27.35M | 87.94%-279K | -772.41%-46.89M |
| Special items of operating profit | 268.19%4.76M | 594.68%4.46M | -34.58%1.29M | 2.17%-902K | 12.28%1.98M | -104.81%-922K | -83.71%1.76M | 18.67%19.18M | 115.83%10.8M | 224.67%16.16M |
| Operating profit | 170.61%1.46M | 65.32%-14.76M | -51,525.00%-2.07M | -167.53%-42.57M | -100.01%-4K | 218.35%63.04M | 271.55%44.84M | 39.76%-53.27M | -31.50%-26.14M | -79.69%-88.43M |
| Financing cost | 19.43%-734K | 28.60%-1.79M | 32.07%-911K | 38.91%-2.5M | 54.39%-1.34M | 24.71%-4.09M | 4.73%-2.94M | 31.49%-5.44M | 25.35%-3.09M | 13.12%-7.93M |
| Earning before tax | 124.33%724K | 63.29%-16.55M | -121.26%-2.98M | -176.45%-45.07M | -103.21%-1.35M | 200.42%58.95M | 243.37%41.9M | 39.08%-58.7M | -21.71%-29.22M | -65.16%-96.36M |
| Tax | 89.67%-60K | ---290K | 73.88%-581K | ---- | 68.50%-2.22M | -3,669.37%-9.67M | -2,958.30%-7.06M | -89.18%271K | 42.77%247K | 176.86%2.51M |
| After-tax profit from continuing operations | 118.67%664K | 62.64%-16.84M | 0.34%-3.56M | -191.46%-45.07M | -110.24%-3.57M | 184.33%49.28M | 220.23%34.84M | 37.74%-58.43M | -21.56%-28.98M | -52.36%-93.86M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | 159.95%4.17M | ---5.93M | ---6.96M | ---- | ---- | ---- | ---- |
| Special items of earning after tax | ---- | ---- | ---- | 159.95%4.17M | ---5.93M | ---6.96M | ---- | ---- | ---- | ---- |
| Earning after tax | 118.67%664K | 58.84%-16.84M | 62.55%-3.56M | -196.64%-40.9M | -127.26%-9.5M | 172.43%42.32M | 220.23%34.84M | 37.74%-58.43M | -21.56%-28.98M | -52.36%-93.86M |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---310K | ---- | ---- | ---- | ---- | ---- |
| Minority profit | ---- | -82.21%-1.09M | 48.06%-161K | 49.10%-596K | 13.17%-310K | -215.63%-1.17M | -643.75%-357K | ---371K | ---48K | ---- |
| Shareholders should account for profits from continuing business | ---- | 64.59%-15.75M | ---- | -188.16%-44.47M | ---3.26M | --50.45M | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | 159.95%4.17M | ---5.93M | ---6.96M | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 119.55%664K | 60.92%-15.75M | 63.04%-3.4M | -192.67%-40.3M | -126.11%-9.19M | 174.91%43.49M | 221.66%35.2M | 38.14%-58.06M | -21.36%-28.93M | -52.36%-93.86M |
| Basic earnings per share | 116.67%0.0001 | 65.06%-0.0029 | 64.71%-0.0006 | -202.47%-0.0083 | -125.76%-0.0017 | 175.00%0.0081 | 222.22%0.0066 | 38.29%-0.0108 | -20.00%-0.0054 | -49.57%-0.0175 |
| Diluted earnings per share | 116.67%0.0001 | 61.33%-0.0029 | 64.71%-0.0006 | -192.59%-0.0075 | -125.76%-0.0017 | 175.00%0.0081 | 222.22%0.0066 | 38.29%-0.0108 | -20.00%-0.0054 | -49.57%-0.0175 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.